The goal of this pilot study is to obtain preliminary information on the tolerability and
efficacy of extended release guanfacine (trade name Intuniv) in children with Tourette
Disorder (TD, also called Tourette syndrome).
Phase:
Phase 4
Details
Lead Sponsor:
Yale University
Collaborators:
Icahn School of Medicine at Mount Sinai New York University Shire University of South Florida